期刊文献+

微量白蛋白尿:2型糖尿病慢性并发症的关键标志 被引量:17

Microalbuminuria:the key signs of chronic complications of type 2 diabetes.
原文传递
导出
摘要 微量白蛋白尿的出现是肾小球滤过膜损伤的结果,是糖尿病肾损害的最早临床征象;伴微量白蛋白尿的糖尿病患者其心血管病变的发生率及病死率明显增高。对糖尿病微量白蛋白尿期患者进行针对可能导致病情加重的多个危险因素的强化治疗,包括改变生活方式、严格控制血糖、RAS系统阻断、严格降压、他汀类调脂及抗凝等能延缓或阻止病变的进展。 microalbumin is the result of the glomerular filtration membrane injury and the first clinical sign of diabetic kidney damage. The cardiovascular disease incidence and mortality of diabetic with mieroalbuminuria is significantly increased. The intensive treatment of risk factors that may aggravate their condition, including life style changes, strict glycemic control, blocking the RAS, and strict control of the elevated blood pressure, lipid-lowering and anticoagulant treatment can delay or pre, cent the disease's progress.
作者 胡雪 邹大进
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第3期199-202,共4页 Chinese Journal of Practical Internal Medicine
关键词 微量白蛋白尿 糖尿病肾病 心血管疾病 microalbuminuria diabetic nephropathy cardiovascular disease
  • 相关文献

参考文献13

  • 1Tabaei BP, AI-Kassab AS, Ilag LL, et al. Does microalbuminuria predict diabetic nephropathy? [ J ]. Diabetes Care, 2001,24 : 1560.
  • 2Dagan B,Tabenkin H, Rakover Y, et al. Micro-albuminuria and ischemic heart disease in non insulin-dependent diabetes[ J]. Harefuah, 1994,126:377 - 380,426.
  • 3Mattock M B,Barnes D J, Viberti G, et al. Micro-albuminuria and coronary heart disease in NIDDM:An incidence study [J]. Diabetes, 1998,47: 1786 - 1792.
  • 4Sasaki A, Oikana S, Toyota T. Microalbuminuria is closely related to diabetic maeroangiopathy [J]. Diabetes Res Clin Pract, 1999, 44:35 -40.
  • 5UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with 2 di- abetes ( UKPDS 33 ) [J]. Lancet, 1998,352 (9131):837 - 853.
  • 6Nakamura T, Ushiyama C, Osada S, et al. Pioglitazone reduce urinary podocyte excretion in type 2 diabetes patients with microalbuminuria[J]. Metabolism ,2001,50 : 1193 - 1196.
  • 7ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuia receive angiotensin converting enzyme inhibitors? A meta-analysis of individual patient data[J]. Ann Intern Med ,2001,134:370 - 379.
  • 8Viberti GC, Wheelden NM. For the microalbuminuria reduction with VALsartan (MARVAL) study. Investigators : microalbuminuria reduction with valsartan in patients with the type 2 diabetes mellitus : a blood pressure-independent effect [ J ]. Circulation, 2002, 106:672 - 678.
  • 9UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [J]. BMJ, 1998,317 (7160):703 -713.
  • 10Mogensen CE, Neldam S, Tikkanen L, et al. Randomised controlled trial of dual blockage of renninangiotensin system in patients with hypertension, microalbuminuria, and non-insulin depent diabetes. The candesartan and lisinopril microalbuminuria study[ J]. BMJ ,2000,321 (7224) : 1440 - 1444.

同被引文献148

引证文献17

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部